Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Eden Pharma Announces the Appointment of Mike Parker to Board of Directors
Eden Pharma, the company disrupting the CBD health and wellness industry, announces the appointment of Mike […]
Regeneron and CytomX Announce Strategic Research Collaboration for Cancer Treatment
Regeneron Pharmaceuticals and CytomX Therapeutics has announced a collaboration and licensing agreement to create conditionally-activated […]
Navamedic ASA Acquires Innovative Antibiotics Product for Hospital Use in the Nordic Region
Navamedic has signed an agreement with its partner InfoRLife SA (subsidiary of ACS Dobfar S.p.A.) […]
Optibrium Appoints Ian Smith as Chief Technology Officer (CTO)
Optibrium, a leading developer of software and AI solutions for drug discovery, today announced the […]
RedBrick AI Raises US$4.6M in Funding to Accelerate the Development of Healthcare AI
Health-tech AI platform RedBrick AI is today announcing a US$4.6M seed funding round to accelerate the […]
ViroCell Strengthens Senior Management Team with Appointment of Nick Maishman as COO
ViroCell Biologics, founded by the UK’s most prolific academic viral vector manufacturing team, today announces […]
FUJIFILM Healthcare Europe partners with The Royal College of Surgeons of Edinburgh
FUJIFILM Healthcare Europe, a leading provider of medical imaging solutions, has become an organisational partner […]
Vial Has Added NEXT Oncology, a Global Network of Phase I Cancer Research Centers, to their Preferred Site Network
Vial has added NEXT Oncology to their Preferred Site Network (PSN). Founded by renowned oncologist Dr. Anthony W. […]
Dr. Cheryl Pegus, Former Walmart EVP of Health & Wellness, Joins Morgan Health
Dr. Cheryl Pegus, a nationally-recognized leader for her work to deliver affordable, high-quality care to millions of […]
Quell Therapeutics Appoints Luke Devey, BMBCh, Ph.D. as Chief Medical Officer
Quell Therapeutics Ltd, a world leader in developing engineered T-regulatory (Treg) cell therapies for serious […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more